Abstract

Nausea and Vomiting in Hospice Patients

Author(s): Boomsma Diane

Issue: Jul/Aug 2000 - Compounding for Hospice and Cancer Patients

Page(s): 250-251

Download in electronic PDF format for $75
  • Nausea and Vomiting in Hospice Patients Page 1
  • Nausea and Vomiting in Hospice Patients Page 2

Abstract

One of the most distressing conditions that can affect a hospice patient is nausea. The author covers the pathways leading to emesis and gastric motility and provides a chart listing medications and their sites of action. She concludes that the pharmacist’s knowledge of medications, their mechanism of action and pathways and limitations and combinations that enhance efficacy is crucial to the success of a medication protocol.

Related Keywords

  • 5-HT3
  • antagonist
  • antiemetic
  • antimuscarinic
  • benzodiazepines
  • cancer
  • cannabinoids
  • chemoreceptor
  • chemotherapy
  • corticosteroids
  • D2
  • D2/HT3
  • emesis
  • emetic
  • gastrointestinal
  • GI
  • hospice
  • nausea
  • trigger zone
  • vomiting
  • vomiting center

Related Categories

  • CANCER AND AIDS
  • HOSPICE/PALLIATIVE CARE

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2000
Pg. 250-251
Nausea and Vomiting in Hospice Patients
Author(s): Boomsma Diane
Mar/Apr 2006
Pg. 95-98
ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient
Author(s): Moon Richard B
Mar/Apr 2013
Pg. 113-123
Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities
Author(s): Zur Eyal
Mar/Apr 2004
Pg. 126-129
Basics of Compounding for the Treatment of Warts
Author(s): Allen Loyd V Jr
Jan/Feb 2013
Pg. 66
Granisetron 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2008
Pg. 460-462
Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration
Author(s): Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
Jul/Aug 2012
Pg. 339
Ondansetron Hydrochloride 2-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2005
Pg. 235-237
Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration
Author(s): Trissel Lawrence A, Xu Quanyun A
Jul/Aug 2000
Pg. 255-256
Custom-Making Medications for the Hospice Patient
Author(s): Horwitz Robert
Mar/Apr 2008
Pg. 156-160
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration
Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008
Pg. 170-173
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration
Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
Nov/Dec 2014
Pg. 520-525
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products
Author(s): Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
Jan/Feb 2018
Pg. 76-85
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection
Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank
Jan/Feb 2018
Pg. 86-94
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride
Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Nov/Dec 2021
Pg. 500
Domperidone 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jan/Feb 2017
Pg. 66-75
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate
Author(s): Wu George, Yeung Stanley, Chen Frank
Jan/Feb 2017
Pg. 76-82
Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride
Author(s): Wu George, Yeung Stanley, Chen Frank
May/Jun 2009
Pg. 220-221
Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report
Author(s): Muller George
May/Jun 2005
Pg. 238-241
Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration
Author(s): Trissel Lawrence A, Xu Quanyun A
Mar/Apr 2006
Pg. 89-93
Hospice from a Compounding Pharmacist's Perspective
Author(s): Jones Marty